These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7346155)

  • 1. Advantages and limitations of pharmacokinetic studies in the rationalization of anticancer therapy: methotrexate and 5-FU.
    Cano JP; Aubert C; Rigault JP; Gilli R; Coassolo P; Monjanel S; Seitz JF; Carcassone Y
    Cancer Treat Rep; 1981; 65 Suppl 3():33-42. PubMed ID: 7346155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients.
    Bocci G; Danesi R; Di Paolo AD; Innocenti F; Allegrini G; Falcone A; Melosi A; Battistoni M; Barsanti G; Conte PF; Del Tacca M
    Clin Cancer Res; 2000 Aug; 6(8):3032-7. PubMed ID: 10955781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 5-fluorouracil pharmacokinetics in whole blood, plasma, and red blood cells in patients with colorectal cancer.
    Wattanatorn W; McLeod HL; Macklon F; Reid M; Kendle KE; Cassidy J
    Pharmacotherapy; 1997; 17(5):881-6. PubMed ID: 9324177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
    Bocci G; Barbara C; Vannozzi F; Di Paolo A; Melosi A; Barsanti G; Allegrini G; Falcone A; Del Tacca M; Danesi R
    Clin Pharmacol Ther; 2006 Oct; 80(4):384-95. PubMed ID: 17015056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics.
    Cano JP; Rigault JP; Aubert C; Carcassonne Y; Seitz JF
    Bull Cancer; 1979; 66(1):67-74. PubMed ID: 420949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic studies of a new fluorinated pyrimidine, 590-S (PH-FU), in human patients].
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2193-8. PubMed ID: 3717963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
    Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].
    Shirasaka T; Taguchi T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():4-18. PubMed ID: 16897967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy.
    Schlemmer HP; Becker M; Bachert P; Dietz A; Rudat V; Vanselow B; Wollensack P; Zuna I; Knopp MV; Weidauer H; Wannenmacher M; van Kaick G
    Cancer Res; 1999 May; 59(10):2363-9. PubMed ID: 10344745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improving the anti-tumor activity of 5-fluorouracil by methotrexate].
    Konishi T; Noie T; Abe T; Agawa S; Furushima K; Ito K; Mafune K; Makuuchi M; Teruya M; Nouchi T
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):431-9. PubMed ID: 10097739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of methotrexate on 5-fluorouracil metabolism and clinical studies with methotrexate and 5-fluorouracil sequential therapy].
    Akazawa S
    Tanpakushitsu Kakusan Koso; 1986 Jun; 31(7):571-8. PubMed ID: 3749514
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-FU split dose; a phase I/II and pharmacokinetic study of a different schedule of the Nordic regimen in advanced colorectal carcinoma.
    Berglund A; Carlsson G; Gustavsson B; Frödin JE; Ragnhammar P; Glimelius B
    Anticancer Res; 2003; 23(2C):1789-94. PubMed ID: 12820460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Tisman G; Wu SJ
    Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of antineoplastic agents (author's transl)].
    Carcassonne Y; Cano JP; Meyer G
    Bull Cancer; 1979; 66(1):39-42. PubMed ID: 311229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
    Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma.
    Remaud G; Boisdron-Celle M; Morel A; Gamelin A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):153-60. PubMed ID: 16061432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
    Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE
    Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple and rapid high-performance liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydrogenase (DPD) activity.
    Ciccolini J; Mercier C; Blachon MF; Favre R; Durand A; Lacarelle B
    J Clin Pharm Ther; 2004 Aug; 29(4):307-15. PubMed ID: 15271097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sequential methotrexate and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1907-10. PubMed ID: 8978795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.